Hospital use of antipsychotic drugs: polytherapy

被引:31
作者
Centorrino, Franca [1 ,2 ,3 ]
Cincotta, Stephanie L. [1 ]
Talamo, Alessandra [1 ,2 ,3 ]
Fogarty, Kate V. [1 ]
Guzzetta, Francesca [1 ]
Saadeh, Mark G. [1 ]
Salvatore, Paola [1 ,2 ,3 ,4 ]
Baldessarini, Ross J. [1 ,2 ,3 ]
机构
[1] Massachusetts Gen Hosp, McLean Div, Schizophrenia Bipolar Disorder & Psychopharmacol, Belmont, MA 02478 USA
[2] Harvard Univ, Sch Med, Dept Psychiat, Boston, MA 02115 USA
[3] Harvard Univ, Sch Med, Neurosci Program, Boston, MA 02115 USA
[4] Univ Parma, Dept Neurosci, Sect Psychiat, I-43100 Parma, Italy
关键词
D O I
10.1016/j.comppsych.2007.08.002
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Objective: Growing acceptance of new psychotropic drugs encouraged a survey of current use of antipsychotic drugs alone and in combinations, with comparisons with previous findings. Method: Records from a random sample of McLean Hospital (Belmont, Mass) inpatients treated with an antipsychotic from March to May 2004 were reviewed for Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, discharge diagnosis; all current psychotropic drug treatments; initial, peak, and final chlorpromazine-equivalent milligram-per-day dose of antipsychotics (APD); initial, peak, and final lithium-equivalent dose (milligram per day) of mood stabilizers (MS); weight change; clinical status at admission and discharge; and days of hospitalization. Results: In the 305 inpatients sampled (n = 184 women, 60.3%), Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, clinical conditions ranked as follows: major affective (n = 161, 52.8%), psychotic (n 99, 32.5%), and other disorders (n = 45, 14.8%). Modern drugs comprised 92% of antipsychotic prescriptions, and quetiapine (Usually at low doses) was most frequently prescribed. "Polytherapy" (simultaneous treatment with >= 2 psychotropic agents) at discharge was identified in 80% of antipsychotic-treated patients. Use of at least 2 antipsychotics (in 23% of cases) was associated with a 2.8-fold increase in total dose vs monotherapy (651 +/- 403 vs 232 +/- 205 mg/d). Total antipsychotic doses also were higher with mood stabilizer (most often divalproex) or sedative (usually high-potency benzodiazepine) cotreatment, use of older neuroleptics, psychotic-disorder diagnoses, and substance use comorbidity. Polytherapy was not associated with superior clinical improvement or shorter hospitalization but was associated with higher body weight. Conclusions: Polytherapy involving antipsychotic drugs continues to increase despite limited empirical evidence for greater effectiveness or of safety of such combinations. (c) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:65 / 69
页数:5
相关论文
共 10 条
[1]  
[Anonymous], GOODMAN GILMANS PHAR
[2]   Long-term combination therapy versus monotherapy with lithium and carbamazepine in 46 bipolar I patients [J].
Baethge, C ;
Baldessarini, RJ ;
Mathiske-Schmidt, K ;
Hennen, J ;
Berghöfer, A ;
Müller-Oerlinghausen, B ;
Bschor, T ;
Adli, M ;
Bauer, M .
JOURNAL OF CLINICAL PSYCHIATRY, 2005, 66 (02) :174-182
[3]  
BALDESSARINI RJ, 1995, AM J PSYCHIAT, V152, P1038
[4]   Use of combinations of antipsychotics: McLean Hospital inpatients, 2002 [J].
Centorrino, F ;
Fogarty, KV ;
Sani, G ;
Salvatore, P ;
Cincotta, SL ;
Hennen, J ;
Guzzetta, F ;
Talamo, A ;
Saadeh, MG ;
Baldessarini, RJ .
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2005, 20 (07) :485-492
[5]   Antipsychotic drug use: McLean Hospital, 2002 [J].
Centorrino, F ;
Fogarty, KV ;
Sani, G ;
Salvatore, P ;
Cimbolli, P ;
Baldessarini, RJ .
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2005, 20 (05) :355-358
[6]   Inpatient antipsychotic drug use in 1998, 1993, and 1989 [J].
Centorrino, F ;
Eakin, M ;
Bahk, WM ;
Kelleher, JP ;
Goren, J ;
Salvatore, P ;
Egli, S ;
Baldessarini, RJ .
AMERICAN JOURNAL OF PSYCHIATRY, 2002, 159 (11) :1932-1935
[7]   Antipsychotic combination therapy in schizophrenia. A review of efficacy and risks of current combinations [J].
Freudenreich, O ;
Goff, DC .
ACTA PSYCHIATRICA SCANDINAVICA, 2002, 106 (05) :323-330
[8]   The increasing use of polypharmacotherapy for refractory mood disorders: 22 years of study [J].
Frye, MA ;
Ketter, TA ;
Leverich, GS ;
Huggins, T ;
Lantz, C ;
Denicoff, KD ;
Post, RM .
JOURNAL OF CLINICAL PSYCHIATRY, 2000, 61 (01) :9-15
[9]  
Ghaemi SN, 2002, MED PSYCHIATRY, V17, P35
[10]   Chlorpromazine equivalent doses for the newer atypical antipsychotics [J].
Woods, SW .
JOURNAL OF CLINICAL PSYCHIATRY, 2003, 64 (06) :663-667